2m 2m 2m 2m 2m 2m 2m
CAMP4 THERAP (CAMP)
NASDAQ
$4.49+$0.010 (+0.22%)
Price as of Aug 21, 2026 7:30 PM EDT- $281.1MMarket Cap
- 189.03%1-Year Change
- BiotechnologyIndustry
CAMP4 THERAP (CAMP)
$4.49+$0.010 (+0.22%)
CAMP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.48 | ||
Change | +$0.02 (+0.45%) | ||
Open | $4.50 | ||
High | $4.54 | ||
Low | $4.42 | ||
Previous Close | $4.46 | ||
Volume | 126,862 | ||
30-Day Average Volume | 218,964 | ||
1-Week Change | -17.65% | ||
1-Month Change | 40.44% | ||
1-Year Change | 189.03% | ||
3-Year Change | -72.13% | ||
5-Year Change | -98.25% | ||
Fundamentals | |||
Shares Outstanding | 62.8M | ||
Total Assets | $93.4M | ||
Market Cap | $281.1M | ||
Enterprise Value | $194.7M | ||
Period: QTR TTM FY | |||
Revenue | $1.8M | ||
Net Income | -$33.5M | ||
Free Cash Flow | -$12.8M | ||
EBIT | -$33.5M | ||
EBITDA | -$33.0M | ||
Net Working Capital | $70.9M | ||
EPS | -$0.58 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | 109 | ||
P/B | -406 | ||
P/E | -8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 23 | ||
Last Split Date | 02/02/2024 | ||
Earnings & Revenue